Oxytocin use while Breastfeeding
Drugs containing Oxytocin: Pitocin, Syntocinon
Oxytocin Levels and Effects while Breastfeeding
Summary of Use during Lactation
Oxytocin is an essential lactation hormone released during breastfeeding that appears to have calming effect on the mother. Administration of exogenous oxytocin to mothers having difficulty in breastfeeding has not been clearly shown to have a beneficial effect on lactation success or in the treatment of breast engorgement. It might be of benefit in women who have lost the neuronal connection between the breast and hypothalamus. Effects on the infant are unlikely when given during breastfeeding. Numerous studies suggest that oxytocin given during labor can negatively affect breastfeeding, possibly by reducing sucking behavior in the newborn in a dose-dependent manner, although study methodology and consistency has varied considerably. One study found that all rhythmic reflexes, the antigravity reflex, and total primitive neonatal reflexes were inhibited by intrapartum oxytocin administration, unrelated to dose, which could adversely affect breastfeeding.
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Intranasal oxytocin is reportedly used by some midwives in Switzerland as a galactogogue.
A small study found no difference in symptoms between subcutaneous oxytocin 2.5 international units daily and placebo after 3 days of treatment for breast engorgement.
An early randomized, placebo-controlled trial used oxytocin nasal spray in the mothers of newborns, but lactation management fell far short of what is considered acceptable nowadays. The study found that the spray might be useful in decreasing breast engorgement slightly in the mothers of fullterm infants, but no difference was found in the average infant weight loss between birth and day 4 in the oxytocin and placebo groups.
Two similarly designed trials studied oxytocin nasal spray in mothers of preterm newborns who were pumping milk for their infants. The first studied mothers of infants born before 38 weeks and used a total of 3 units of intranasal oxytocin (Syntocinon-Sandoz, 40 units/mL) before pumping each breast for10 minutes a breast pump four times daily. Among primiparous mothers, milk production during days 2 to 5 days postpartum was 1964 mL in those who used oxytocin and 510 mL in those who received placebo spray. Because of the large and statistically significant effect of oxytocin among primiparous women, the trial was stopped after only 8 primiparous mothers had been studied. No statistically significant difference was found between oxytocin and placebo among 4 multiparous women who were attempting to breastfeed for the first time. The paper did not report giving the mothers any instructions in lactation technique.
Fifty-one mothers who delivered an infant of less than 35 weeks gestation were studied. Twenty-seven mothers used 4 units of intranasal oxytocin (Syntocinon-Novartis, 40 units/mL), and 24 mothers received an identical placebo spray before pumping with a breast pump. All mothers were given instructions on using hand massage before pumping and advised to pump every 3 hours. No difference in milk production over the first 5 days postpartum was found between mothers who received oxytocin (median 667 mL) and placebo (median 530 mL), although women receiving oxytocin produced slightly more milk on day 2 of the study. Parity had no effect in this study.
Several factors might explain the differences in findings between the studies. Because of the great interpatient variability in milk production documented in the recent study and the small number of patients in the first study, the finding in the earlier study may have been due to chance. A 50% higher dose of oxytocin was used in the first study, which may have caused a greater effect. Another plausible explanation is the good lactation support given to mothers in the recent larger study that seemed to be lacking in the early study.
Two case reports indicate that oxytocin nasal spray may facilitate letdown in tetraplegic women who have lost the neuronal connection between the nipple and the hypothalamus.
xxx Logistic regress of data from 585 mothers who had epidural analgesia during labor found that mothers who had received exogenous oxytocin had a 3.3 times greater risk of delayed onset of lactation than women who did not.
An observational study of 20 primiparous women found that those who were exclusively breastfeeding at 3 months (63%) had received a lower dose of oxytocin during labor (mean total dosage 1363 mIU) than those who were not exclusively breastfeeding (mean total dosage 3088 mIU). This result was attributed to an inhibitory effect on neonatal sucking by the infant caused by oxytocin.
A small, nonrandomized cohort study found that the newborn infants whose mothers received synthetic oxytocin to induce or maintain labor had a decreased level of prefeeding organization one hour after birth.
A retrospective cohort study in Spain compared breastfeeding outcomes between mothers who received oxytocin during labor (n = 189) and mothers who did not, including those who delivered via elective Cesarean section (n = 127). Mothers who received oxytocin during the first and second stages of labor had a 45% increased risk of bottle feeding and a 129% increased risk of breastfeeding discontinuation by 3 months of age. Effects were most pronounced in women under 27 years of age.
A small prospective study in California compared women who received an epidural infusion of fentanyl and ropivacaine to mothers who did not receive an epidermal during labor. All mothers had normal vaginal deliveries and their infants had 1 uninterrupted hour of skin-to-skin contact immediately postpartum. The study found inverse relationships between the amount of fentanyl and the amount of oxytocin received during labor and the time of the first suckling. Because women who received more fentanyl also tended to receive more oxytocin, the study could not clearly separate the effects of the two drugs.
A small prospective cohort study in Spain followed mothers by telephone postpartum to determine their breastfeeding status. Mothers who had received oxytocin during labor were breastfeeding at a similar rate as those who had not at 1, 3 and 6 months postpartum.
1. Niwayama R, Nishitani S, Takamura T et al. Oxytocin mediates a calming effect on postpartum mood in primiparous mothers. Breastfeed Med. 2017;12:103-9. PMID: 28103103
2. Olza Fernandez I, Marin Gabriel M, Malalana Martinez A et al. Newborn feeding behaviour depressed by intrapartum oxytocin: a pilot study. Acta Paediatr. 2012;101:749-54. PMID: 22452314
3. Jonas W, Johansson LM, Nissen E et al. Effects of intrapartum oxytocin administration and epidural analgesia on the concentration of plasma oxytocin and prolactin, in response to suckling during the second day postpartum. Breastfeed Med. 2009;4:71-82. PMID: 19210132
4. Jordan S, Emery S, Watkins A et al. Associations of drugs routinely given in labour with breastfeeding at 48 hours: analysis of the Cardiff births survey. BJOG. 2009;116:1622-32. PMID: 19735379
5. Garcia-Fortea P, Gonzalez-Mesa E, Blasco M et al. Oxytocin administered during labor and breastfeeding: A retrospective cohort study. J Matern Fetal Neonatal Med. 2014;27:1598-603. PMID: 24289796
6. Bell AF, White-Traut R, Rankin K. Fetal exposure to synthetic oxytocin and the relationship with prefeeding cues within one hour postbirth. Early Hum Dev. 2013;89:137-43. PMID: 23084698
7. Wiklund I, Norman M, Uvnas-Moberg K et al. Epidural analgesia: breast-feeding success and related factors. Midwifery. 2009;25:e31-8. PMID: 17980469
8. Davey M, Gibson K. Intervention in labour and early breastfeeding outcomes. Arch Dis Child Fetal Neonatal Ed. 2014;99 (Suppl 1):A81. Abstract PD.02. 25021365
9. Brimdyr K, Cadwell K, Widstrom AM et al. The association between common labor drugs and suckling when skin-to-skin during the first hour after birth. Birth. 2015;42:319-28. PMID: 26463582
10. Gu V, Feeley N, Gold I et al. Intrapartum synthetic oxytocin and its effects on maternal well-being at 2 months postpartum. Birth. 2016;43:28-35. PMID: 26554749
11. Erickson EN, Emeis CL. Breastfeeding outcomes after oxytocin use during childbirth: An integrative review. J Midwifery Womens Health. 2017;62:397-417. PMID: 28759177
12. Marin Gabriel MA, Olza Fernandez I, Malalana Martinez AM et al. Intrapartum synthetic oxytocin reduce the expression of primitive reflexes associated with breastfeeding. Breastfeed Med. 2015;10:209-13. PMID: 25785487
13. Winterfeld U, Meyer Y, Panchaud A, Einarson A. Management of deficient lactation in Switzerland and Canada: A survey of midwives' current practices. Breastfeed Med. 2012;7:317-8. PMID: 22224508
14. Ingelman-Sundberg A. Early puerpereal breast engorgement. Acta Obstet Gynecol Scand. 1953;32:399-402. PMID: 13138066
15. Mangesi L, Zakarija-Grkovic I. Treatments for breast engorgement during lactation. Cochrane Database Syst Rev. 2016;6:CD006946. PMID: 27351423
16. Luhman LA. The effect of intranasal oxytocin on lactation. Obstet Gynecol. 1963;21:713-7. PMID: 13931578
17. Ruis H, Rolland R, Doesburg W et al. Oxytocin enhances onset of lactation among mothers delivering prematurely. Br Med J. 1981;283:340-2. PMID: 6788318
18. Fewtrell MS, Loh K, Blake A et al. Randomised, double-blind trial of oxytocin nasal spray in mothers expressing breast milk for preterm infants. Arch Dis Child Fetal Neonatal Ed. 2006;91:F169-74. PMID: 16223754
19. Cowley KC. Psychogenic and pharmacologic induction of the let-down reflex can facilitate breastfeeding by tetraplegic women: A report of 3 cases. Arch Phys Med Rehabil. 2005;86:1261-4. PMID: 15954070
20. Fernandez-Canadas Morillo A, Marin Gabriel MA, Olza Fernandez I et al. The relationship of the administration of intrapartum synthetic oxytocin and breastfeeding initiation and duration rates. Breastfeed Med. 2017. PMID: 28165755
CAS Registry Number
Pituitary Hormones, Posterior
LactMed Record Number
Last Revision Date
Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
More about oxytocin
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 2 Reviews – Add your own review/rating
- Drug class: uterotonic agents
Other brands: Pitocin